• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估 COVID-19 感染病死率的年龄特异性:系统评价、荟萃分析及公共政策意义。

Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.

机构信息

Dartmouth College, Hanover, USA.

National Bureau for Economic Research, Cambridge, USA.

出版信息

Eur J Epidemiol. 2020 Dec;35(12):1123-1138. doi: 10.1007/s10654-020-00698-1. Epub 2020 Dec 8.

DOI:10.1007/s10654-020-00698-1
PMID:33289900
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7721859/
Abstract

Determine age-specific infection fatality rates for COVID-19 to inform public health policies and communications that help protect vulnerable age groups. Studies of COVID-19 prevalence were collected by conducting an online search of published articles, preprints, and government reports that were publicly disseminated prior to 18 September 2020. The systematic review encompassed 113 studies, of which 27 studies (covering 34 geographical locations) satisfied the inclusion criteria and were included in the meta-analysis. Age-specific IFRs were computed using the prevalence data in conjunction with reported fatalities 4 weeks after the midpoint date of the study, reflecting typical lags in fatalities and reporting. Meta-regression procedures in Stata were used to analyze the infection fatality rate (IFR) by age. Our analysis finds a exponential relationship between age and IFR for COVID-19. The estimated age-specific IFR is very low for children and younger adults (e.g., 0.002% at age 10 and 0.01% at age 25) but increases progressively to 0.4% at age 55, 1.4% at age 65, 4.6% at age 75, and 15% at age 85. Moreover, our results indicate that about 90% of the variation in population IFR across geographical locations reflects differences in the age composition of the population and the extent to which relatively vulnerable age groups were exposed to the virus. These results indicate that COVID-19 is hazardous not only for the elderly but also for middle-aged adults, for whom the infection fatality rate is two orders of magnitude greater than the annualized risk of a fatal automobile accident and far more dangerous than seasonal influenza. Moreover, the overall IFR for COVID-19 should not be viewed as a fixed parameter but as intrinsically linked to the age-specific pattern of infections. Consequently, public health measures to mitigate infections in older adults could substantially decrease total deaths.

摘要

确定 COVID-19 的特定年龄感染病死率,为保护脆弱年龄组的公共卫生政策和沟通提供信息。通过在线搜索已发表的文章、预印本和政府报告,对 COVID-19 的流行情况进行了研究,这些研究报告在 2020 年 9 月 18 日之前公开发布。系统评价共纳入了 113 项研究,其中 27 项研究(涵盖 34 个地理位置)符合纳入标准,并纳入了荟萃分析。使用流行数据和研究期间中点后 4 周报告的死亡人数计算特定年龄的 IFR,反映了死亡和报告的典型滞后。Stata 中的元回归程序用于分析年龄与感染病死率(IFR)之间的关系。我们的分析发现,COVID-19 的年龄和 IFR 之间呈指数关系。对于儿童和年轻成年人,特定年龄的 IFR 非常低(例如,10 岁时为 0.002%,25 岁时为 0.01%),但逐渐增加到 55 岁时为 0.4%,65 岁时为 1.4%,75 岁时为 4.6%,85 岁时为 15%。此外,我们的结果表明,地理区域之间人口 IFR 的变化约 90%反映了人口年龄结构的差异,以及相对脆弱年龄组接触病毒的程度。这些结果表明,COVID-19 不仅对老年人而且对中年成年人都有危险,对于后者,感染病死率比每年发生致命车祸的风险高出两个数量级,比季节性流感危险得多。此外,COVID-19 的总体 IFR 不应被视为一个固定参数,而应与特定年龄的感染模式密切相关。因此,减轻老年人感染的公共卫生措施可以大大减少总死亡人数。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/7762748/5146f426f510/10654_2020_698_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/7762748/1f343bd3d583/10654_2020_698_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/7762748/2efd56b5183d/10654_2020_698_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/7762748/6c202cd11580/10654_2020_698_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/7762748/fd70dd96b6ca/10654_2020_698_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/7762748/5acf9cb3f55d/10654_2020_698_Fig5a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/7762748/5146f426f510/10654_2020_698_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/7762748/1f343bd3d583/10654_2020_698_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/7762748/2efd56b5183d/10654_2020_698_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/7762748/6c202cd11580/10654_2020_698_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/7762748/fd70dd96b6ca/10654_2020_698_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/7762748/5acf9cb3f55d/10654_2020_698_Fig5a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c25d/7762748/5146f426f510/10654_2020_698_Fig6_HTML.jpg

相似文献

1
Assessing the age specificity of infection fatality rates for COVID-19: systematic review, meta-analysis, and public policy implications.评估 COVID-19 感染病死率的年龄特异性:系统评价、荟萃分析及公共政策意义。
Eur J Epidemiol. 2020 Dec;35(12):1123-1138. doi: 10.1007/s10654-020-00698-1. Epub 2020 Dec 8.
2
A systematic review and meta-analysis of published research data on COVID-19 infection fatality rates.对已发表的关于 COVID-19 感染病死率的研究数据的系统回顾和荟萃分析。
Int J Infect Dis. 2020 Dec;101:138-148. doi: 10.1016/j.ijid.2020.09.1464. Epub 2020 Sep 29.
3
Variation in the COVID-19 infection-fatality ratio by age, time, and geography during the pre-vaccine era: a systematic analysis.在疫苗接种前时代,按年龄、时间和地理位置划分的 COVID-19 感染病死率变化:系统分析。
Lancet. 2022 Apr 16;399(10334):1469-1488. doi: 10.1016/S0140-6736(21)02867-1. Epub 2022 Feb 24.
4
Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021.大流行防范与新冠疫情:对2020年1月1日至2021年9月30日期间177个国家的感染率、死亡率以及与防范相关的背景因素进行的探索性分析。
Lancet. 2022 Apr 16;399(10334):1489-1512. doi: 10.1016/S0140-6736(22)00172-6. Epub 2022 Feb 1.
5
Estimating The Infection Fatality Rate Among Symptomatic COVID-19 Cases In The United States.估计美国有症状的 COVID-19 病例中的感染病死率。
Health Aff (Millwood). 2020 Jul;39(7):1229-1236. doi: 10.1377/hlthaff.2020.00455. Epub 2020 May 7.
6
Estimating effective infection fatality rates during the course of the COVID-19 pandemic in Germany.估算德国 COVID-19 大流行期间的有效感染病死率。
BMC Public Health. 2021 Jun 5;21(1):1073. doi: 10.1186/s12889-021-11127-7.
7
SARS-CoV-2 infection fatality rate after the first epidemic wave in Mexico.墨西哥首轮疫情过后的 SARS-CoV-2 感染病死率。
Int J Epidemiol. 2022 May 9;51(2):429-439. doi: 10.1093/ije/dyac015.
8
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
9
Representative estimates of COVID-19 infection fatality rates from four locations in India: cross-sectional study.来自印度四个地区的 COVID-19 感染病死率的代表性估计值:横断面研究。
BMJ Open. 2021 Oct 5;11(10):e050920. doi: 10.1136/bmjopen-2021-050920.
10
No Effects of Meteorological Factors on the SARS-CoV-2 Infection Fatality Rate.气象因素对 SARS-CoV-2 感染病死率无影响。
Biomed Environ Sci. 2021 Nov 20;34(11):871-880. doi: 10.3967/bes2021.120.

引用本文的文献

1
The interplay of influenza and COVID-19 in Germany, January 2020 - December 2022: a study of competitive disease dynamics with quarantine measures and partial cross-immunity.2020年1月至2022年12月德国流感与新冠病毒的相互作用:一项关于隔离措施和部分交叉免疫下竞争性疾病动态的研究
BMC Public Health. 2025 Sep 9;25(1):3044. doi: 10.1186/s12889-025-24362-z.
2
paramix: An R package for parameter discretisation in compartmental models, with application to calculating years of life lost.Paramix:一个用于房室模型参数离散化的R软件包,并应用于计算寿命损失年数。
PLoS Comput Biol. 2025 Sep 8;21(9):e1013420. doi: 10.1371/journal.pcbi.1013420. eCollection 2025 Sep.
3

本文引用的文献

1
High SARS-CoV-2 seroprevalence in children and adults in the Austrian ski resort of Ischgl.奥地利伊施格尔滑雪胜地儿童和成人中新冠病毒血清阳性率很高。
Commun Med (Lond). 2021;1(1):4. doi: 10.1038/s43856-021-00007-1. Epub 2021 Jun 30.
2
Low Seroprevalence of SARS-CoV-2 in Rhode Island blood donors during may 2020 as determined using multiple serological assay formats.2020 年 5 月,使用多种血清学检测方法在罗得岛献血者中检测到的 SARS-CoV-2 血清阳性率较低。
BMC Infect Dis. 2021 Aug 25;21(1):871. doi: 10.1186/s12879-021-06438-4.
3
The real seroprevalence of SARS-CoV-2 in France and its consequences for virus dynamics.
Utilizing artificial intelligence as an arbitrary tool in managing difficult COVID-19 cases in critical care medicine.
在危重症医学中利用人工智能作为管理复杂新冠病例的一种任意工具。 (注:原句表述稍显奇怪,正常语境下“arbitrary”应为“arbitrary”拼写有误,推测可能想表达“辅助的”等更合适的意思,但按照要求严格翻译为上述内容 )
World J Crit Care Med. 2025 Sep 9;14(3):102808. doi: 10.5492/wjccm.v14.i3.102808.
4
SARS-CoV-2 antibody responses in children exhibit higher FcR engagement and avidity than in adults.儿童对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的抗体反应比成人表现出更高的Fc受体结合能力和亲和力。
Nat Commun. 2025 Aug 23;16(1):7879. doi: 10.1038/s41467-025-63263-y.
5
Rewired type I IFN signaling is linked to age-dependent differences in COVID-19.重新布线的I型干扰素信号传导与COVID-19中年龄依赖性差异有关。
Cell Rep Med. 2025 Aug 19;6(8):102285. doi: 10.1016/j.xcrm.2025.102285.
6
A network-based model to assess vaccination strategies for the COVID-19 pandemic by using Bayesian optimization.一种基于网络的模型,用于通过贝叶斯优化评估针对新冠疫情的疫苗接种策略。
Chaos Solitons Fractals. 2024 Apr;181. doi: 10.1016/j.chaos.2024.114695. Epub 2024 Mar 14.
7
Molecular insights into the bidirectional link between anxiety and COVID-19: a combined clinical and bioinformatics approach.焦虑与2019冠状病毒病双向联系的分子见解:临床与生物信息学相结合的方法
Front Psychiatry. 2025 Jul 22;16:1643355. doi: 10.3389/fpsyt.2025.1643355. eCollection 2025.
8
Mediator complex subunit MED23 dampens antiviral innate immunity by restricting RIG-I expression.中介体复合物亚基MED23通过限制RIG-I的表达来抑制抗病毒先天性免疫。
PLoS Biol. 2025 Jul 24;23(7):e3003294. doi: 10.1371/journal.pbio.3003294. eCollection 2025 Jul.
9
Forecasting life expectancy in São Paulo City, Brazil, amidst the COVID-19 pandemic.在新冠疫情期间预测巴西圣保罗市的预期寿命
Popul Health Metr. 2025 Jul 6;23(1):36. doi: 10.1186/s12963-025-00397-7.
10
A two-stage random-effects estimator for meta-analyses of the value per statistical life.一种用于统计生命价值元分析的两阶段随机效应估计量。
PLoS One. 2025 Jun 13;20(6):e0324630. doi: 10.1371/journal.pone.0324630. eCollection 2025.
法国真实的 SARS-CoV-2 血清流行率及其对病毒动力学的影响。
Sci Rep. 2021 Jun 15;11(1):12597. doi: 10.1038/s41598-021-92131-0.
4
Prevalence of antibody positivity to SARS-CoV-2 following the first peak of infection in England: Serial cross-sectional studies of 365,000 adults.英国首次感染高峰后新冠病毒抗体阳性率:对36.5万名成年人的系列横断面研究
Lancet Reg Health Eur. 2021 May;4:100098. doi: 10.1016/j.lanepe.2021.100098. Epub 2021 May 2.
5
Assessing the age- and gender-dependence of the severity and case fatality rates of COVID-19 disease in Spain.评估西班牙新冠肺炎疾病严重程度和病死率的年龄及性别依赖性。
Wellcome Open Res. 2020 Jun 2;5:117. doi: 10.12688/wellcomeopenres.15996.1. eCollection 2020.
6
Estimation of seroprevalence of novel coronavirus disease (COVID-19) using preserved serum at an outpatient setting in Kobe, Japan: A cross-sectional study.利用日本神户市门诊留存血清估计新型冠状病毒病(COVID-19)血清阳性率:一项横断面研究。
Clin Epidemiol Glob Health. 2021 Jul-Sep;11:100747. doi: 10.1016/j.cegh.2021.100747. Epub 2021 Apr 19.
7
Seroprevalence and correlates of SARS-CoV-2 neutralizing antibodies from a population-based study in Bonn, Germany.基于德国波恩的一项人群研究的 SARS-CoV-2 中和抗体的血清阳性率和相关因素。
Nat Commun. 2021 Apr 9;12(1):2117. doi: 10.1038/s41467-021-22351-5.
8
Infection fatality rate of COVID-19 inferred from seroprevalence data.基于血清流行率数据推断的 COVID-19 感染病死率。
Bull World Health Organ. 2021 Jan 1;99(1):19-33F. doi: 10.2471/BLT.20.265892. Epub 2020 Oct 14.
9
Frailty and comorbidity in predicting community COVID-19 mortality in the U.K. Biobank: The effect of sampling.衰弱和合并症对英国生物库社区 COVID-19 死亡率的预测:抽样的影响。
J Am Geriatr Soc. 2021 May;69(5):1128-1139. doi: 10.1111/jgs.17089. Epub 2021 Mar 5.
10
COVID-19 antibody seroprevalence in Santa Clara County, California.加利福尼亚州圣克拉拉县的新冠病毒抗体血清流行率。
Int J Epidemiol. 2021 May 17;50(2):410-419. doi: 10.1093/ije/dyab010.